See Cooperative Research and Development Agreement.
Glossary
CRADA
02.27.12
-
Collaborations & Alliances | Drug Development
ProBioGen, LAVA to Develop Cell Lines for Bispecific Candidate
ProBioGen will conduct cell line development of a novel gamma-delta bsTCE using its CHO.RiGHT expression platform.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Thibault Jonckheere Named CEO of Exothera
The viral vector CDMO spinoff of Univercells is making an intranasal vaccine candidate for Covid-19 treatment.Tim Wright, Editor, Contract Pharma
-
Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Recro, Astex Enter Drug Development Alliance
Expands partnership for oral solid dose drug product services.Kristin Brooks
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
OncoTEX, Sterling Pharma Sign Clinical Mfg. Pact
Sterling will produce clinical material for OncoTex’s novel platinum-resistant oncology drug candidate, OxaliTEX, for use in clinical trials.Kristin Brooks
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Biomunex, Onward Ink Strategic Antibody Development Pact
Exclusive worldwide license and development agreement will leverage Biomunex' next gen bi- and multi-specific antibody platform in hematological malignancies.Kristin Brooks
